Multicentral Randomized Controlled Clinical Trials about Treatment of Perimenopausal Syndrome with Electroacupuncture of Sanyinjiao (SP 6)
|更新时间:2023-08-11
|
Multicentral Randomized Controlled Clinical Trials about Treatment of Perimenopausal Syndrome with Electroacupuncture of Sanyinjiao (SP 6)
Acupuncture ResearchIssue 4, Pages: 262-266(2008)
作者机构:
1. 安徽中医学院针灸骨伤临床学院
2. 安徽农业大学校医院
3. 安徽中医学院第一附属医院
4. 安徽中医学院附属针灸医院
作者简介:
基金信息:
DOI:
CLC:
Published:2008
稿件说明:
移动端阅览
XIA Xiao-hong, HU ling, QIN Zheng-yu1, et al. Multicentral Randomized Controlled Clinical Trials about Treatment of Perimenopausal Syndrome with Electroacupuncture of Sanyinjiao (SP 6)[J]. Acupuncture research, 2008, (4): 262-266.
DOI:
XIA Xiao-hong, HU ling, QIN Zheng-yu1, et al. Multicentral Randomized Controlled Clinical Trials about Treatment of Perimenopausal Syndrome with Electroacupuncture of Sanyinjiao (SP 6)[J]. Acupuncture research, 2008, (4): 262-266.DOI:
Multicentral Randomized Controlled Clinical Trials about Treatment of Perimenopausal Syndrome with Electroacupuncture of Sanyinjiao (SP 6)
Objective To evaluate the effect of electroacupuncture (EA) of Sanyinjiao (SP 6) on perimenopausal syndrome (PMS). Methods Multicentral randomized controlled trials and single blind test were adopted in the present study. A total of 157 PMS patients were randomly divided into EA group (n=81) and medication group (n=76) . EA (2/100 Hz
8-10 mA) was applied to bilateral Sanyinjiao (SP 6)
3 times a week and for 3 months (mon). Patients of medication group were treated by oral administration of nylestriol
2 mg/time
twice a mon for 3 mon. For PMS patients
medroxyprogesterone (6 mg/d
for 10 days) was added from the third mon on after the treatment. The therapeutic effect was evaluated by using "symptoms-signs score scale"
and changes of serum estradiol (E2)
follicle stimulating hormone (FSH) and luteotrophic hormone (LH) were detected by chemiluminescence immune assay. Kupperman index was determined before and after the treatment. Results In comparison with pre-treatment
Kupperman index of EA group decreased significantly (P<0.01). After the treatment
contents of serum FSH and LH of EA group decreased significantly (P<0.01)
while serum E2 contents of EA and medication groups increased significantly (P<0.01). Serum LH and E2 levels of EA group were significantly lower than those of medication group (P<0.05). No significant differences were found between two groups in Kupperman index
markedly-effective rates and total effective rates (P>0.05). Conclusion EA of Sanyinjiao (SP 6) is able to regulate serum E2
FSH and LH levels and effectively improve per-imenopausal syndrome.